Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial

Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial

Yuanbin Chen,1,* Lin Lin,1,* Lei Wu,1 Yinji Xu,1 Johannah L Shergis,2 Anthony L Zhang,2 Zehuai Wen,1 Christopher Worsnop,3 Cliff Da Costa,4 Frank Thien,5 Charlie C Xue1,2 1The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine and G...

Detaylı Bibliyografya
Asıl Yazarlar:	Chen Y, Lin L, Wu L, Xu Y, Shergis JL, Zhang AL, Wen Z, Worsnop C, Da Costa C, Thien F, Xue CC
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Dove Medical Press 2020-03-01
Seri Bilgileri:	International Journal of COPD
Konular:	copd ginseng exacerbation quality of life randomized controlled trial
Online Erişim:	https://www.dovepress.com/effect-of-panax-ginseng-g115-capsules-versus-placebo-on-acute-exacerba-peer-reviewed-article-COPD

Benzer Materyaller

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
Yazar:: Whittaker H, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Acute exacerbations of COPD
Yazar:: W MaxNee
Baskı/Yayın Bilgisi: (2003-05-01)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
Yazar:: Calverley PMA, ve diğerleri
Baskı/Yayın Bilgisi: (2017-11-01)

COPD Exacerbation Syndrome: The Spanish Perspective on an Old Dilemma
Yazar:: Soler-Cataluña JJ, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

No association between exacerbation frequency and stroke in patients with COPD
Yazar:: Windsor C, ve diğerleri
Baskı/Yayın Bilgisi: (2016-02-01)

COPD exacerbation: factors influencing hospitalization duration
Yazar:: Gashynova K.Yu.
Baskı/Yayın Bilgisi: (2015-03-01)

COPD exacerbation: factors influencing hospitalization duration.
Yazar:: K. Yu. Gashynova
Baskı/Yayın Bilgisi: (2015-03-01)

Exacerbations of COPD
Yazar:: Pavord ID, ve diğerleri
Baskı/Yayın Bilgisi: (2016-02-01)

Magnesium Administration For COPD Exacerbation: A Systematic Review and Meta-analysis
Yazar:: Hala Alzaid, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Information Needs in COPD After an Educational Programme: Influence in Exacerbations and Admissions
Yazar:: Amado CA, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

COPD exacerbation: anthropometric characteristics of patients and the frequency of hospital admissions
Yazar:: Gashynova K.Y.
Baskı/Yayın Bilgisi: (2014-11-01)

Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study
Yazar:: Fukuchi Y, ve diğerleri
Baskı/Yayın Bilgisi: (2016-04-01)

Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study
Yazar:: Fahy WA, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
Yazar:: Miłkowska-Dymanowska J, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

Understanding the Gaps in the Reporting of COPD Exacerbations by Patients: A Review
Yazar:: Paul Jones, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Colds as predictors of the onset and severity of COPD exacerbations
Yazar:: Johnston NW, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

Management of Asthma and COPD Exacerbations in Adults in the ICUKey PointsClinical QuestionClinical Question
Yazar:: Stephen A. Mein, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2025-03-01)

Oxidant and antioxidant balance in stable COPD patients and during acute COPD exacerbations
Yazar:: Kubra Cansiz, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions
Yazar:: Kallis C, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Variability of blood eosinophil count and prognosis of COPD exacerbations
Yazar:: Sandra Martínez-Gestoso, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]
Yazar:: Domenico Lorenzo Urso
Baskı/Yayın Bilgisi: (2017-07-01)

A Nomogram for Predicting Severe Exacerbations in Stable COPD Patients
Yazar:: Chen X, ve diğerleri
Baskı/Yayın Bilgisi: (2020-02-01)

Ginseng Genome Database: an open-access platform for genomics of Panax ginseng
Yazar:: Murukarthick Jayakodi, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

The recent advances of phenotypes in acute exacerbations of COPD
Yazar:: Zhou A, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD
Yazar:: Nicholas P. Williams, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Sputum bacteriology and antibiotic sensitivity pattern in COPD exacerbation in India
Yazar:: Prakhar Sharma, ve diğerleri
Baskı/Yayın Bilgisi: (2017-10-01)

An atypical acute exacerbation of COPD due to Aspergillus fumigatus
Yazar:: Cuneyt Tetikkurt, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Panax ginseng
Yazar:: Alyaa Majid
Baskı/Yayın Bilgisi: (2019-05-01)

Panax ginseng
Yazar:: Alyaa Majid
Baskı/Yayın Bilgisi: (2019-05-01)

InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations
Yazar:: Dave Singh, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Risk factors for prolonged hospitalization as a marker for difficult-to-manage exacerbations of chronic obstructive lung disease (COPD): the DiMECO Study
Yazar:: Dorina Esendağlı, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

A mRNA panel for differentiation between acute exacerbation or pneumonia in COPD patients
Yazar:: Wilhelm Bertrams, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Acute exacerbations of COPD: risk factors for failure and relapse
Yazar:: Mantero M, ve diğerleri
Baskı/Yayın Bilgisi: (2017-09-01)

Renaming COPD exacerbations: the UK respiratory nursing perspective
Yazar:: Christine Mwasuku, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
Yazar:: Yang HH, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Elevated levels of arginase activity are related to inflammation in patients with COPD exacerbation
Yazar:: Marcel Jose Rodríguez-Guzmán, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study
Yazar:: Youngmee Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma
Yazar:: Ane Aamli Gagnat, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
Yazar:: Sean Duffy, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia
Yazar:: Søgaard M, ve diğerleri
Baskı/Yayın Bilgisi: (2016-03-01)